ReTaMed ApS: Financial statements 2023
CVR: 39608405
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ReTaMed ApS (CVR 39608405) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -13,795 and a net result of DKK -7,846 compared with DKK -12,783 the year before. Equity in the 2023 report amounted to DKK 100,577. The solvency ratio was 40.6%.
- Gross Profit
- DKK -13,795
- Profit/Loss
- DKK -7,846
- Equity
- DKK 100,577
- Total Assets
- DKK 248,032
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -14 t. | -8 t. | 101 t. | - |
| 2022 | - | -18 t. | -13 t. | 108 t. | 0 |
| 2021 | - | -60 t. | -57 t. | 121 t. | 1 |
| 2020 | - | 350 t. | -238 t. | 178 t. | 1 |
| 2019 | - | 358 t. | -159 t. | 416 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ReTaMed ApS has published its annual report for 2022. Gross profit came to DKK -17,823, and the net result was DKK -12,783.
About ReTaMed ApS
ReTaMed ApS is a Danish company of the type Anpartsselskab based in Esbjerg, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Henrik Fomsgaard-Knudsen. The company is owned by ReTaMed Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,022 compared with DKK -861 the year before. Equity in the 2025 report amounted to DKK 50,000.